TRIM21 and dermatomyositis: The mortality rate for DM-related SIH is 50%, with the rate exceeding 70% for anti-MDA5 and anti-Ro52 antibodies positivity, which is higher than that for anti-MDA5 or Ro52 antibody-single positive or negative SIH (6).